Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis

ClinicalTrials.gov ID: NCT02826603

Public ClinicalTrials.gov record NCT02826603. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 1:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-week, Randomized, Double-blind Study of Secukinumab (300 mg) Compared to Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Demonstrate superiority of secukinumab over ustekinumab in treatment of moderate to severe plaque psoriasis.

Study identification

NCT ID
NCT02826603
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,114 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 21, 2016
Primary completion
Jul 8, 2018
Completion
Jul 8, 2018
Last update posted
Jul 8, 2019

2016 – 2018

United States locations

U.S. sites
123
U.S. states
33
U.S. cities
106
Facility City State ZIP Site status
Novartis Investigative Site Anniston Alabama 36207
Novartis Investigative Site Birmingham Alabama 35205
Novartis Investigative Site Birmingham Alabama 35233
Novartis Investigative Site Mobile Alabama 36608
Novartis Investigative Site Glendale Arizona 85308
Novartis Investigative Site Phoenix Arizona 85018
Novartis Investigative Site Phoenix Arizona 85032
Novartis Investigative Site Scottsdale Arizona 85259
Novartis Investigative Site Scottsdale Arizona 85260
Novartis Investigative Site Tucson Arizona 85724
Novartis Investigative Site Fort Smith Arkansas 72916
Novartis Investigative Site Hot Springs Arkansas 71913
Novartis Investigative Site Rogers Arkansas 72758
Novartis Investigative Site Bakersfield California 93309
Novartis Investigative Site Beverly Hills California 90211
Novartis Investigative Site California City California 93405
Novartis Investigative Site Encinitas California 92024
Novartis Investigative Site Fresno California 93710
Novartis Investigative Site Fullerton California 92835
Novartis Investigative Site Irvine California 92697
Novartis Investigative Site Los Angeles California 90033
Novartis Investigative Site Oceanside California 92056
Novartis Investigative Site Sacramento California 95819
Novartis Investigative Site San Diego California 92103
Novartis Investigative Site San Diego California 92117
Novartis Investigative Site San Diego California 92123
Novartis Investigative Site Santa Monica California 90404
Novartis Investigative Site Santa Rosa California 95405
Novartis Investigative Site Denver Colorado 80220
Novartis Investigative Site Trumbull Connecticut 06611
Novartis Investigative Site Aventura Florida 33180
Novartis Investigative Site Boca Raton Florida 33486
Novartis Investigative Site Cape Coral Florida 33990
Novartis Investigative Site Coral Gables Florida 33134
Novartis Investigative Site Fort Myers Florida 33916
Novartis Investigative Site Jacksonville Florida 32216
Novartis Investigative Site Orange Park Florida 32073
Novartis Investigative Site South Miami Florida 33143
Novartis Investigative Site Tampa Florida 33609
Novartis Investigative Site Tampa Florida 33624
Novartis Investigative Site West Palm Beach Florida 33409
Novartis Investigative Site Alpharetta Georgia 30022
Novartis Investigative Site Atlanta Georgia 30342
Novartis Investigative Site Macon Georgia 31217
Novartis Investigative Site Marietta Georgia 30060
Novartis Investigative Site Newnan Georgia 30263
Novartis Investigative Site Skokie Illinois 60077
Novartis Investigative Site Springfield Illinois 62703
Novartis Investigative Site Indianapolis Indiana 46256
Novartis Investigative Site New Albany Indiana 47150
Novartis Investigative Site Louisville Kentucky 40241
Novartis Investigative Site Owensboro Kentucky 42301
Novartis Investigative Site Owensboro Kentucky 42303
Novartis Investigative Site Baton Rouge Louisiana 70809
Novartis Investigative Site Lake Charles Louisiana 70601
Novartis Investigative Site Lake Charles Louisiana 70605
Novartis Investigative Site Metairie Louisiana 70006
Novartis Investigative Site New Orleans Louisiana 70112
Novartis Investigative Site Rockville Maryland 20850
Novartis Investigative Site Rockville Maryland 20852
Novartis Investigative Site Beverly Massachusetts 01915
Novartis Investigative Site Boston Massachusetts 02111
Novartis Investigative Site Boston Massachusetts 02114
Novartis Investigative Site Brighton Massachusetts 02135
Novartis Investigative Site Quincy Massachusetts 02169
Novartis Investigative Site Fridley Minnesota 55432
Novartis Investigative Site Jackson Mississippi 39216-4505
Novartis Investigative Site Saint Joseph Missouri 64506
Novartis Investigative Site St Louis Missouri 63104
Novartis Investigative Site St Louis Missouri 63117
Novartis Investigative Site St Louis Missouri 63141
Novartis Investigative Site Las Vegas Nevada 89128
Novartis Investigative Site East Windsor New Jersey 08520
Novartis Investigative Site Verona New Jersey 07044
Novartis Investigative Site Albuquerque New Mexico 87106
Novartis Investigative Site Forest Hills New York 11375
Novartis Investigative Site New York New York 10016
Novartis Investigative Site New York New York 10025 1737
Novartis Investigative Site New York New York 10075
Novartis Investigative Site Rochester New York 14623
Novartis Investigative Site Chapel Hill North Carolina 27516
Novartis Investigative Site Charlotte North Carolina 28209
Novartis Investigative Site Durham North Carolina 27710
Novartis Investigative Site Greensboro North Carolina 27401
Novartis Investigative Site High Point North Carolina 27262
Novartis Investigative Site Rocky Mount North Carolina 27804
Novartis Investigative Site Winston-Salem North Carolina 27157
Novartis Investigative Site Cincinnati Ohio 45242
Novartis Investigative Site Cleveland Ohio 44106-5028
Novartis Investigative Site Columbus Ohio 43210
Novartis Investigative Site Dublin Ohio 43016
Novartis Investigative Site Fairborn Ohio 45324
Novartis Investigative Site Oklahoma City Oklahoma 73103
Novartis Investigative Site Oklahoma City Oklahoma 73112
Novartis Investigative Site Oregon City Oregon 97045
Novartis Investigative Site Portland Oregon 97210
Novartis Investigative Site Portland Oregon 97223
Novartis Investigative Site Exton Pennsylvania 19341
Novartis Investigative Site Jenkintown Pennsylvania 19046
Novartis Investigative Site Pittsburgh Pennsylvania 15213-3403
Novartis Investigative Site Plymouth Meeting Pennsylvania 19462
Novartis Investigative Site Anderson South Carolina 29621
Novartis Investigative Site Charleston South Carolina 29407
Novartis Investigative Site Greer South Carolina 29651
Novartis Investigative Site Goodlettsville Tennessee 37072-2301
Novartis Investigative Site Knoxville Tennessee 37922
Novartis Investigative Site Murfreesboro Tennessee 37130
Novartis Investigative Site Nashville Tennessee 37203
Novartis Investigative Site Arlington Texas 76011
Novartis Investigative Site Austin Texas 78705
Novartis Investigative Site Dallas Texas 75230
Novartis Investigative Site Dallas Texas 75231
Novartis Investigative Site Houston Texas 77056
Novartis Investigative Site Pflugerville Texas 78660
Novartis Investigative Site San Antonio Texas 78229
Novartis Investigative Site Murray Utah 84107
Novartis Investigative Site Norfolk Virginia 23507
Novartis Investigative Site Everett Washington 98201
Novartis Investigative Site Seattle Washington 98101
Novartis Investigative Site Spokane Washington 99204
Novartis Investigative Site Walla Walla Washington 99362
Novartis Investigative Site Wenatchee Washington 98801
Novartis Investigative Site Madison Wisconsin 53717

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02826603, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2019 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02826603 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →